Who Owns TherapeuticsMD Stock?
NASDAQ: TXMDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 31.73%
- Held by insiders
- 9.04%
- Institutional holders
- 55
- Institutions 31.7%
- Insiders 9.0%
- Public and other 59.2%
Who owns TherapeuticsMD stock?
Institutional investors own about 31.7% of TherapeuticsMD's shares, spread across 55 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 9.04% of TXMD.
The largest institutional holders are Rubric Capital Management LP (10.30%), Clearline Capital, LP (5.49%) and Vanguard Capital Management LLC (3.06%). Together, the top 10 institutions control 29.8% of shares outstanding. In their latest filings, 3 of the top 10 institutions increased their TXMD positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of TXMD
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Rubric Capital Management LP | 1.19M | 10.30% | 0.0% |
| Clearline Capital, LP | 635.22K | 5.49% | 0.0% |
| Vanguard Capital Management LLC | 353.70K | 3.06% | 0.0% |
| Tejara Capital Ltd | 344.48K | 2.98% | -0.4% |
| Adar1 Capital Management, LLC | 342.45K | 2.96% | +63.7% |
| Renaissance Technologies, LLC | 146.60K | 1.27% | +0.3% |
| Morgan Stanley | 129.22K | 1.12% | 0.0% |
| Blackrock Inc. | 115.14K | 0.99% | 0.0% |
| Geode Capital Management, LLC | 105.85K | 0.91% | -3.6% |
| Citadel Advisors Llc | 86.09K | 0.74% | +26.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of TXMD
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 244.32K | 2.11% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 109.38K | 0.95% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 61.01K | 0.53% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 15.32K | 0.13% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 14.84K | 0.13% |
| Dimensional ETF Trust-Dimensional US Core Equity 2 ETF | 4.83K | 0.04% |
| Dimensional ETF Trust-Dimensional US Sustainability Core 1 ETF | 3.61K | 0.03% |
| Gabelli Investor Funds Inc-The Gabelli ABC Fund | 3.60K | 0.03% |
| Dimensional ETF Trust-Dimensional US Core Equity 1 ETF | 3.08K | 0.03% |
| Gabelli 787 Fund, Inc.-Enterprise Mergers and Acquisitions Fund | 1.00K | 0.01% |
Frequently asked questions
Who is the largest shareholder of TherapeuticsMD?
Rubric Capital Management LP is the largest institutional shareholder of TXMD, owning 10.30% of shares outstanding (1.19M shares) as of its latest 13F filing.
What percentage of TherapeuticsMD is owned by institutions?
Institutions own about 31.7% of TXMD shares and 34.9% of the public float.
How much of TherapeuticsMD do insiders own?
Insiders, such as officers and directors, own about 9.04% of TXMD shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.